July 5, 2023
Renewal: Message from CEO & President
February 1, 2016
Minophagen Pharmaceutical Got Approved for Targretin®Capsules 75mg in Japan
April 2, 2012
Eisai and Minophagen Pharmaceutical Conclude License Agreement Concerning the Development and Commercialization of Cutaneous T-Cell Lymphoma Treatment Bexarotene in Asia, Oceania, the Middle East and Eastern Europe, etc.
March 30, 2011
Eisai and Minophagen Pharmaceutical Conclude Japan License Agreement For Cutaneous T-Cell Lymphoma Treatment Bexarotene
You need Adobe Reader to view and print the web pages.Adobe Reader is freeware; you can download it from the download site.